@chumps_mcgee @CoalemusGuy @PythiaR That’s how I read it too, but if you’re changing your inclusion approach based on new evidence for this biomarker, surely you’re going to consider including it as a secondary outcome measure if data supportive. Omission
So far, Altmetric has seen
604 X posts from 520 X users, with an upper bound of 3,957,042 followers.
747 followers
371 followers
RT @JAMANeuro: Can a commercial blood test identify Alzheimer disease pathology? Watch this video about a recent JAMA Neurology study. ht…
1,376 followers
823 followers